A*STAR and the National University of Singapore (NUS) have launched a joint laboratory aimed at accelerating the commercialisation of synthetic biology research. The A*STAR SIFBI-NUS Synthetic Biology Joint Lab was established by the A*STAR Singapore Institute of Food and Biotechnology Innovation (A*STAR SIFBI) and NUS Synthetic Biology for Clinical and Technological Innovation (NUS SynCTI). The facility will combine A*STAR SIFBI’s expertise in bioprocess development and scale-up with NUS’ strengths in scientific research and talent development.  Its initial focus will be on nutrition and consumer care, with potential applications in advanced materials and healthcare. Top of Form Bottom of Form The lab will work with companies to develop, test and validate bio-based alternatives to conventional chemical manufacturing processes.  Synthetic biology uses engineered biological systems such as microbes and enzymes to produce ingredients, chemicals and materials. https://sbr.com.sg/healthcare/news/astar-and-nus-launch-synthetic-biology-commercialisation-lab (ICE SINGAPORE)

Fonte notizia: Singapore Business Review, 13 June 2026